David Wiersma is an angel investor based in Tucson, Arizona, United States with 13 known investments, including Halo Labs, Providence Medical Technology, OrthAlign, Cylene Pharmaceuticals, seqWell, Esperance Pharmaceuticals, Q'Apel Medical, Bioinformatics, Cantex Pharmaceuticals, ClearFlow, CyMedica and Dispersol Technologies.
Is David Wiersma a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- Healthcare
Contacts
David Wiersma portfolio companies (13)
- Halo Labs
- Providence Medical Technology
- OrthAlign
- Cylene Pharmaceuticals
- seqWell
- Esperance Pharmaceuticals
- Q'Apel Medical
- Bioinformatics
- Cantex Pharmaceuticals
- ClearFlow
- CyMedica
- Dispersol Technologies
- Rubicon Genomics
Investor Profile
Founders in the listed sector Healthcare, and focus areas Biotech, Diagnostics, Genomics and MedTech will recognize the pattern in this portfolio.
The portfolio and focus above give founders context on whether David Wiersma matches their raise.
Similar investors
Showing 19 of 99
Frequently asked questions
Who is David Wiersma?
David Wiersma is an angel investor based in Tucson, Arizona, United States with 13 known investments on file, among them Halo Labs, Providence Medical Technology and OrthAlign. The sections above list the sectors attached to that record.
What does David Wiersma invest in?
Listed sectors include Healthcare; listed focus areas include Biotech, Diagnostics, Genomics and MedTech. Those tags come from the companies attached to this profile, so they read as a record of what has been backed rather than a stated preference for what comes next.
How do I contact David Wiersma?
An email address, a phone number and a LinkedIn page are on file for David Wiersma. The address stays masked on this page and is readable inside RaiseHunt after you create an account.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal
